Section Arrow
ETON.NASDAQ
- Eton Pharmaceuticals
Quotes are at least 15-min delayed:2026/09/28 19:15 EDT
After Hours
Last
 59.26
+0.08 (+0.14%)
Bid
59.2
Ask
60
High 60.52 
Low 59.18 
Volume 4.66K 
Regular Hours (Closed)
Last
 59.18
+1.5 (+2.60%)
Day High 
59.7154 
Prev. Close
57.68 
1-M High
63.6 
Volume 
390.72K 
Bid
59.2
Ask
60
Day Low
56.01 
Open
57.68 
1-M Low
53.6 
Market Cap 
1.65B 
Currency 美元 
P/E 147.9 
%Yield -- 
10-SMA 56.67 
20-SMA 58.04 
50-SMA 53.35 
52-W High 66.37 
52-W Low 14.27 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
0.39/2.33
Enterprise Value
1.67B
Balance Sheet
Book Value Per Share
1.63
Cash Flow
Cash Flow Yield
0.01
Income Statement
Total Revenue
79.95M
Operating Revenue Per Share
1.02
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
HLNHaleon plc9.17-0.09-0.97%19.3PE
After Hours 9.1406 -0.0294 -0.32%
VTRSViatris18.27+0.44+2.47%-- 
After Hours 18.25 -0.02 -0.11%
SCYXSCYNEXIS Inc4.62+0.23+5.24%-- 
After Hours 4.56 -0.06 -1.30%
ELANElanco Animal Health22.45+0.14+0.63%-- 
After Hours 22.45 0 0.00%
HIMSHims & Hers Health28.78-0.64-2.18%-- 
After Hours 28.7907 +0.0107 +0.04%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.